Guadalquiver, Jean .
HRN: 25-99-96 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/02/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/02/2024
10/09/2024
IV
330
Q8h
T/c Generalized Tetanus
Waiting Final Action
Indication: Empiric Type of Infection: Central Nervous System Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes